https://scholars.lib.ntu.edu.tw/handle/123456789/468839
標題: | Intralymphatic Spread is a Rare Finding Associated with Poor Prognosis in Diffuse Large B-Cell Lymphoma with Extranodal Involvements | 作者: | Chieh-Lung Cheng Su, Yung-Cheng Chao, Tsu-Yi CHUNG-WU LIN SHENG-CHIEH CHOU MING YAO SUNG-HSIN KUO SHAN-CHI YU |
公開日期: | 2018 | 出版社: | Lippincott Williams and Wilkins | 卷: | 42 | 期: | 5 | 起(迄)頁: | 616-624 | 來源出版物: | American Journal of Surgical Pathology | 摘要: | Intralymphatic spread is common in solid cancers, but has been rarely studied in lymphomas. Review of 635 extranodal specimens from 475 diffuse large B-cell lymphoma (DLBCL) patients revealed intralymphatic spread in 10 surgical resection specimens from 10 patients including 9 de novo DLBCLs and 1 Richter transformation. The prevalence in de novo DLBCL with extranodal involvements was 1.65%. The most common involved site of intralymphatic spread was the gastrointestinal tract, followed by the female genital tract and breasts. Lymphatic vessels, lined by D2-40-positive endothelial cells, were expanded by lymphoma cells, reminiscent of intravascular lymphoma or tumor emboli. None of the involved lymphatic vessels were located in the mucosa. Patients with intralymphatic spread had a trend of lower overall response rate and a trend of higher progressive disease than those without intralymphatic spread. Compared with patients without intralymphatic spread, those patients with intralymphatic spread had a shorter median overall survival (14.3 vs. 96.2 mo; P=0.004) and a shorter median progression-free survival (11.2 vs. 64.2 mo; P=0.01), respectively. Multivariate analyses showed that intralymphatic spread was an independent poor prognostic factor for overall survival (hazard ratio, 3.029; 95% confidence interval, 1.315-6.978; P=0.009), irrespective of the National Comprehensive Cancer Network-International Prognostic Index, B symptoms, and serum albumin levels. Among patients who underwent surgical resection, intralymphatic spread was still an independent prognostic factor. In conclusion, our study demonstrated extranodal intralymphatic spread in DLBCL. Inspiringly, this rare morphologic finding may serve as a new negative prognostic indicator in DLBCL with extranodal involvements. ? 2018 Wolters Kluwer Health, Inc. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045682865&doi=10.1097%2fPAS.0000000000001045&partnerID=40&md5=1160e3360e20fc9caeec36ee46cc5ff9 https://scholars.lib.ntu.edu.tw/handle/123456789/468839 |
ISSN: | 0147-5185 | DOI: | 10.1097/PAS.0000000000001045 | SDG/關鍵字: | tumor marker; adult; aged; chemistry; diffuse large B cell lymphoma; disease exacerbation; epidemiology; female; human; immunohistochemistry; lymph node metastasis; lymph vessel; male; middle aged; mortality; pathology; prevalence; retrospective study; risk factor; Taiwan; time factor; treatment outcome; very elderly; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Lymphatic Vessels; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prevalence; Progression-Free Survival; Retrospective Studies; Risk Factors; Taiwan; Time Factors; Treatment Outcome |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。